Evidence map›Paper›PMID 22659029›Full record

ArticleClinical immunology (Orlando, Fla.)2012

Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus.

Melissa A Cunningham, Osama S Naga, Jackie G Eudaly, Jennifer L Scott, Gary S Gilkeson

Abstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Sex as a modifier of genetic risk for type 1 diabetes.Diabetes, obesity & metabolism · 2025
    Review
  5. Review
  6. The aging ovary impairs acute stroke outcomes.Journal of neuroinflammation · 2023
    Article
  7. Review
  8. Methylation ofDiagnostics (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Inhibition of human macrophage activationFrontiers in immunology · 2022
    Article
  11. Article
  12. Review
  13. Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  14. Article
  15. Glucocorticoids, Sex Hormones, and Immunity.Frontiers in immunology · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Melissa A CunninghamMedical University of South Carolina, Division of Rheumatology and Immunology and Ralph H. Johnson Veterans Affairs Hospital, Charleston, SC 29425, USA.
Osama S Naga
Jackie G Eudaly
Jennifer L Scott
Gary S Gilkeson
Medical University of South Carolina · USRalph H. Johnson VA Medical Center · US

Funding

Training Grant in Inflammatory and Fibrosing DiseasesT32AR050958 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DIANE L KAMEN · 2005 to 2026
$4.2M
NIAMS NIH HHS T32 AR050958
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a disease that disproportionately affects females. Despite significant research effort, the mechanisms underlying the female predominance in this disease are largely unknown. Previously, we showed that estrogen receptor alpha knockout (ERαKO) lupus prone female mice had significantly less pathologic renal disease and proteinuria, and significantly prolonged survival. Since autoantibody levels and number and percentage of B/T cells were not significantly impacted by ERα genotype, we hypothesized that the primary benefit of ERα deficiency in lupus nephritis was via modulation of the innate immune response. Using BMDCs and spleen cells/B cells from female wild-type or ERαKO mice, we found that ERαKO-derived cells have a significantly reduced inflammatory response after stimulation with TLR agonists. Our results indicate that the inflammatory response to TLR ligands is significantly impacted by the presence of ERα despite the absence of estradiol, and may partially explain the protective effect of ERα deficiency in lupus-prone animals.

Indexed as

AnimalsB-LymphocytesBone Marrow CellsCpG IslandsCytokinesDendritic CellsDisease Models, AnimalEstrogen Receptor alphaFemaleGuanosineLupus Erythematosus, SystemicMiceMice, KnockoutSpleenToll-Like ReceptorsCytokinesEstrogen Receptor alphaGuanosineloxoribineToll-Like Receptors

Identifiers

PMID22659029
PMCPMC3737583
OpenAlexW2010293505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.